cse91_vb

cse91_vb - CSE91 Earlydetec2onofcancersusing computa2on...

Info iconThis preview shows pages 1–10. Sign up to view the full content.

View Full Document Right Arrow Icon
11/5/09 Bafna CSE91 Early detec2on of cancers using computa2on Vineet Bafna, UCSD
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
11/5/09 Bafna A combinatorial puzzle Given: a graph with nodes laid out on a line Select a subset of nodes 2 nodes that are connected by an edge cannot both be in the subset No adjacent pair is apart by more than 1 2 3 5 4 7 9 8 11 10 6
Background image of page 2
How hard is the puzzle Number of nodes in the graph: n (5000) Total length of the line : k (500) Minimum number of nodes: Number of ways of selecting subsets 11/5/09 Bafna k n k = 5000 500 = 10 500
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Today We talk about smarter ways to solve this puzzle And, we show how to use the solution for early detection of cancer. 11/5/09 Bafna
Background image of page 4
Gleevec? 11/5/09 Bafna
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
11/5/09 Bafna The Gleevec story The Food and Drug Administration approved a new kind of anti-cancer drug yesterday after a swift, two-and-a-half- month review of clinical data. Drugs accepted for priority review usually take six months to approve. Gleevec's quick approval rests on its immediate and striking results in treating patients with chronic myelogenous leukemia, one of the four main types of leukemia. In one trial of 54 patients, Gleevec caused their blood counts to revert to normal in more than 90 percent of cases and cancerous cells to disappear altogether in 13 percent, with generally few side e f ects. …Gleevec was the ''±rst molecularly targeted drug'' and showed ''the incredible value of developing a drug against a target'' when the errant component of a cancer cell could be identi±ed.
Background image of page 6
Cancer? In normal cells, when the DNA is damaged beyond repair, the cells commit `suicide’ (apoptosis) In cancer, these cells proliferate, invade other tissues. 11/5/09 Bafna
Background image of page 7

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
11/5/09 Bafna The Science behind Gleevec Fusions observed in leukemia, lymphoma, and sarcomas “Philadelphia Translocation” Drugs target this fusion protein
Background image of page 8
What did we learn? Something in the DNA of a tumor cell changes.
Background image of page 9

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 10
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 08/31/2011 for the course CSE 91 taught by Professor Staff during the Fall '08 term at UCSD.

Page1 / 41

cse91_vb - CSE91 Earlydetec2onofcancersusing computa2on...

This preview shows document pages 1 - 10. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online